US63633D1046
US63633D1046
National Health Investors, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 3.18B EUR | 3.75B EUR | 3.92B EUR | 3.69B EUR |
Enterprise Value | 4.44B EUR | 4.99B EUR | 5.16B EUR | 4.83B EUR |
Valuation Multiples | ||||
Trailing P/E | 18.74x | 22.46x | 26.46x | 34.15x |
Forward P/E | 19.33x | -- | -- | -- |
Price to Sales | 7.31x | 8.67x | 9.76x | 12.88x |
Price to Book | 2.03x | 2.38x | 2.59x | 2.42x |
EV/Revenue | 10.18x | 11.56x | 12.86x | 16.88x |
EV/EBITDA | 15.32x | 17.33x | 18.18x | 23.13x |
Price to FCF (P/FCF) | 18.52x | 15.06x | 16.09x | 19.41x |
EV/FCF | 25.8x | 20.08x | 21.2x | 25.43x |
FCF Yield | 5.4% | 6.64% | 6.21% | 5.15% |